Search clinical trials for: Optune(NOVOTTF-100A)

Total 3049 results

ActiveO Inc.

Completed

Safety and Effectiveness Study of the AO-1000 Device to Treat Contained Herniated Discs

Disk, Herniated

Canada
HeadSense Medical
Oslo University Hospital

Completed

Development and Evaluation of the ICP Waveform Tracing Capabilities and Safety of HS-1000 Device

Brain Injuries | Intracranial Hypertension

Norway
HemaQuest Pharmaceuticals Inc.

Completed

A Study of HQK-1001 in Patients With Sickle Cell Disease

Sickle Cell Disease | Sickle Cell Anemia | Sickle Cell Disorders | Hemoglobin S Disease | Sickling Disorder Due to Hemoglobin S

United States, Lebanon, Canada, Egypt, Jamaica
Pfizer

Completed

The Effects of Fx-1006A on Transthyretin Stabilization and Clinical Outcome Measures in Patients With Non-V30M Transthyretin Amyloidosis

Transthyretin-associated Amyloidosis With Polyneuropathy

United States, France, Germany, Italy
Center for Eye Research Australia
Novartis Pharmaceuticals

Terminated

Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging

Macular Degeneration | Choroidal Neovascularization

Australia
Asklepios Biopharmaceutical, Inc.

Recruiting

A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)

Muscular Dystrophy | Limb Girdle Muscular Dystrophy | LGMD2I | LGMD | Limb-Girdle Muscular Dystrophy Type 2 | LGMD2 | FKRP | FKRP Mutation | Fukutin Related Protein

United States
Dalhousie University
Canadian Institutes of Health Research (CIHR); NewLink Genetics Corporation

Completed

Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (VSVΔG-ZEBOV)

Ebola Viruses
Neurona Therapeutics

Not yet recruiting

Effect of NRTX-1001, a Cellular Therapy Product, for the Treatment of Refractory Bilateral TLE

Epilepsy, Temporal Lobe
Hangzhou Zenshine Pharmaceuticals Co., Ltd.

Terminated

Dose-Escalation and Dose-Expansion Study of ZX-101A in Patients With Relapsed/Resistant or Refractory Advanced Hematologic Malignancies

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Non-hodgkin Lymphoma

United States
NeuroEM Therapeutics, Inc.
University of South Florida Health / Byrd Alzheimer's Institute

Unknown

Transcranial Electromagnetic Treatment Against Alzheimer's Disease

Alzheimer Disease | Alzheimer Disease, Late Onset

United States
HeadSense Medical
Rigshospitalet, Denmark

Unknown

Comparison of the Non-invasive ICP HeadSense Monitor vs Lumbar CSF Pressure Measurement

Intracranial Hypertension

Denmark, Germany, Netherlands
HeadSense Medical
State Medical Center, Republic of Armenia

Completed

An Evaluation of Non-invasive ICP Monitoring in Patients Undergoing Routine Care

Stroke

Armenia
Pfizer

Completed

The Effects Of Fx-1006A On Transthyretin Stabilization And Clinical Outcome Measures In Patients With V122I Or Wild-Type TTR Amyloid Cardiomyopathy

Cardiomyopathy

United States
Allegro Ophthalmics, LLC

Withdrawn

Safety Study of ALG- 1001 to Treat Diabetic Macular Edema

Diabetic Macular Edema

Mexico
Pfizer

Completed

Pharmacokinetics Of Orally Administered Fx-1006A In Subjects With Hepatic Dysfunction

Mild Hepatic Dysfunction | Moderate Hepatic Dysfunction

South Africa
Memory Pharmaceuticals
Stanley Medical Research Institute

Completed

Safety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I Disorder

Bipolar Disorder With Manic or Mixed Episodes

United States
Sumitomo Pharma America, Inc.
BehaVR LLC

Completed

A Randomized, Controlled Study of Two At-Home Self-Guided Virtual Reality Interventions for Adults With Social Anxiety Disorder. (BVR-100-102)

Social Anxiety Disorder (SAD)

United States
Baptist Health South Florida
Bristol-Myers Squibb; NovoCure Ltd.

Terminated

Trial of Combination TTF(Optune), Nivolumab Plus/Minus Ipilimumab for Recurrent Glioblastoma

Recurrent Glioblastoma

United States
San Diego State University

Recruiting

Elucidating the Minimal Effective Dose of Prunes for Bone Health in Postmenopausal Women

Bone Disease, Metabolic

United States
Shire

Completed

FST-100 in the Treatment of Acute Viral Conjunctivitis

Acute Viral Conjunctivitis

United States, Brazil
ExThera Medical Corporation

Completed

Safety Evaluation of Seraph® 100 to Reduce Bacteremia in Patients on Hemodialysis

Bacteremia | Bacterial Infection

Germany
Medtronic Cardiovascular

Withdrawn

Post Market ATS 3f® Aortic Bioprosthesis, Model 1000, Size 19mm

Heart Valve Diseases

Canada
AbbVie

Recruiting

An Observational Study to Assess Optive MEGA-3 (OM3) on Dry Eye Symptoms and Quality of Life of Adult Participants With Mild to Moderate Dry Eye Disease (DED)

Dry Eye

United States
Lawson Health Research Institute
DePuy Orthopaedics; Johnson & Johnson Medical Companies

Active, not recruiting

Attune With TruMatch TM Personalized Solutions Instruments

Obesity | Osteoarthritis

Canada
University of Erlangen-Nürnberg Medical School

Unknown

Ripasudil 0.4% Eye Drops in Fuchs Endothelial Corneal Dystrophy

Fuchs' Endothelial Dystrophy | Fuchs Dystrophy | Corneal Endothelial Dystrophy | Corneal Endothelial Cell Loss | Cornea Guttata

Germany
Wake Forest University Health Sciences
NovoCure Ltd.

Terminated

A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM)

Cancer of Brain and Nervous System

United States
Pharmacosmos A/S

Completed

Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia (CIA) (PK-CIA-04)

Non-hematological Malignancies
University of Pennsylvania
Tesaro, Inc.; NovoCure Ltd.

Active, not recruiting

Niraparib/TTFields in GBM

Glioblastoma | GBM | Recurrent Glioblastoma

United States
Neurological Associates of West Los Angeles

Enrolling by invitation

Focused Ultrasound for the Treatment of ADHD Symptoms

ADHD

United States
Veralox Therapeutics

Completed

Phase I Study of VLX-1005 in Healthy Subjects

Safety and Tolerability in Healthy Volunteers

United States
HeadSense Medical
University Medical Center Goettingen; Klinikum Darmstadt; Klinikum Stuttgart

Unknown

An Evaluation of a Non-invasive Brain Monitor

Brain Injuries | Brain Neoplasms | Subarachnoid Hemorrhage | Vasospasm, Intracranial | Hydrocephalus

Germany
Quark Pharmaceuticals

Completed

A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery

Acute Kidney Injury

United States, Canada, Germany
HeadSense Medical
Akron Children's Hospital

Withdrawn

Non-invasive Intracranial Pressure (ICP) Monitoring in Pediatric Patients

Intracranial Hypertension

United States
HeadSense Medical
Vanderbilt University Medical Center

Unknown

An Evaluation of HS-1000 Device Capabilities in the Diagnosis and Assessment of Patients After Concussion

Brain Injuries | Brain Concussion

United States
Mayo Clinic
National Institutes of Health (NIH)

Completed

Fat Gain and Cardiovascular Disease Mechanisms

Sleep Apnea Syndromes | Hypertension | Obesity

United States
HemaQuest Pharmaceuticals Inc.

Completed

Phase 1/2 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HQK-1001 Administered Daily in Patients With Sickle Cell Disease

Sickle Cell Disease

United States, Jamaica
Avidity Biosciences, Inc.

Completed

Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients (MARINA)

Myotonic Dystrophy | Myotonic Disorders | Myotonic Dystrophy Type 1 (DM1) | Myotonic Dystrophy 1 | Myotonic Muscular Dystrophy | DM1 | Dystrophy Myotonic | Steinert Disease

United States
Massachusetts General Hospital

Active, not recruiting

Neuromodulation of Mind-Wandering in Depression

Depression

United States
HeadSense Medical
Akron Children's Hospital

Unknown

Indirect Intracranial Pressure Measurement in Patients With Suspected or Documented Concussion

Brain Injuries | Brain Concussion

United States
Merck Sharp & Dohme LLC

Completed

MK-1006 Single Dose Study in Japanese Type 2 Diabetes Patients (MK-1006-005)

Diabetes Mellitus, Non-Insulin-Dependent
HemaQuest Pharmaceuticals Inc.

Terminated

Effects of HQK-1001 in Patients With Sickle Cell Disease

Sickle Cell Disease | Sickle Cell Anemia | Sickle Cell Disorders | Hemoglobin S Disease | Sickling Disorder Due to Hemoglobin S

United States, Lebanon, Egypt, Canada, Jamaica
Pfizer

Completed

Safety and Efficacy Study of Fx-1006A in Patients With Familial Amyloidosis

Familial Amyloid Polyneuropathy

United Kingdom, Spain, United States, Argentina, Brazil, France, Germany, Portugal, Sweden
HemaQuest Pharmaceuticals Inc.

Completed

Phase 1 Placebo Controlled Study of the Safety, Activity and Pharmacokinetics of HQK-1001 in Healthy Subjects

Healthy

United States
Forschungsinstitut für Balneologie und Kurortwissenschaft...

Completed

Mild Water-Filtered Near Infrared Whole-Body-Hyperthermia as an Adjunct in the Treatment of Fibromyalgia

Fibromyalgia

Germany
Curacle Co., Ltd.
Théa Open Innovation, France

Completed

The Study of CU06-1004 in Patients With Diabetic Macular Edema (DME)

Diabetic Macular Edema

United States, Puerto Rico
IRCCS San Raffaele

Not yet recruiting

18F-PSMA PET/MRI for the Diagnosis of Clinically Significant Prostate Cancer

Prostate Cancer
Curacle Co., Ltd.

Recruiting

Phase IIb Clinical Trial for the Efficacy and Safety by CU01-1001 for 24 Weeks in Type 2 DM Patients With Albuminuria

Diabetic Nephropathies

Korea, Republic of
University of Alberta

Recruiting

18F-PSMA-1007 PET/CT in Prostate Cancer - Access Trial 2022 to 2028

Prostate Cancer

Canada
Kiadis Pharma

Withdrawn

Off-the-shelf NK Cells (KDS-1000) as Immunotherapy for COVID-19

Covid19
TaiGen Biotechnology Co., Ltd.
R&G Pharma Studies Co.,Ltd.

Completed

To Evaluate the Safety, Tolerability, and Pharmacokinetics Profiles of TG-1000 in Healthy Volunteers, and the Food Effect on Pharmacokinetics of Single Oral Dose of TG-1000 in Healthy Volunteers.

Healthy Chinese Volunteers

China

Search clinical trials for: Optune(NOVOTTF-100A)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Oman

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations